Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Signs of Puberty

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...

Testosterone: Functions and Regulation

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adult Male Hypogonadism: A Review.

JAMA·2026

Same author

Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management.

The Medical journal of Australia·2026

Same author

Development of Graves orbitopathy after thyroidectomy for thyroid cancer.

JCEM case reports·2026

Same author

Hypothalamic-Pituitary-Testicular Axis Regulation in Men With Type 2 Diabetes.

Clinical endocrinology·2026

Same author

Discordance Between Online Information and Male Hypogonadism Clinical Guidelines: A Global Multilingual Content Analysis.

The Journal of clinical endocrinology and metabolism·2026

Same author

EndoCompass Project: Endocrinology across the Lifespan.

Hormone research in paediatrics·2025

Search research articles

Related Experiment Video

Updated: May 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Hematological changes during androgen deprivation therapy.

Mathis Grossmann¹, Jeffrey D Zajac

¹Department of Medicine, Austin Health/Northern Health, University of Melbourne, Heidelberg, Vic. 3084, Australia. mathisg@unimelb.edu.au

Asian Journal of Andrology

|January 11, 2012

Summary

This summary is machine-generated.

Androgen deprivation therapy (ADT) can cause anemia in men with prostate cancer, potentially impacting quality of life. Further research is needed to understand if treating this anemia improves outcomes.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Related Experiment Videos

Last Updated: May 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Area of Science:

Hematology
Oncology
Endocrinology

Background:

Androgen deprivation therapy (ADT) is a cornerstone treatment for prostate cancer.
ADT affects multiple tissues, including the hematopoietic system, leading to predictable adverse effects.
Anemia is a common consequence of ADT, particularly in elderly or frail patients.

Purpose of the Study:

To review the effects of ADT on the hematopoietic system, focusing on anemia.
To discuss the clinical implications of ADT-associated anemia, including its impact on quality of life and potential mortality.
To highlight the need for further research on ADT's effects on other blood cell lineages.

Main Methods:

Literature review and synthesis of existing preclinical and clinical data.
Analysis of the relationship between ADT, anemia, and patient outcomes in prostate cancer.
Discussion of current understanding and gaps in knowledge regarding ADT's impact on hematopoiesis.

Main Results:

ADT commonly causes normocytic, normochromic anemia, which may exacerbate fatigue and reduce quality of life.
Anemia is an independent risk factor for mortality in prostate cancer patients.
The effects of ADT on neutrophils, lymphocytes, and platelets are less understood but warrant further investigation.

Conclusions:

Awareness of ADT-induced anemia can prevent unnecessary investigations for mild cases.
Assessment and treatment of ADT-associated anemia should be individualized based on severity and patient factors.
Further studies are needed to elucidate ADT's impact on non-erythroid hematopoietic lineages and the clinical significance of these effects.